EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Baohuoside I chemosensitises breast cancer to paclitaxel by suppressing extracellular vesicle/CXCL1 signal released from apoptotic cells

Shengqi Wang, Jing Li, Shang Xu, Neng Wang, Bo Pan, Bowen Yang, Yifeng Zheng, Juping Zhang, Fu Peng, Cheng Peng, Zhiyu Wang iD

Journal of Extracellular Vesicles · 2024

DOI: 10.1002/jev2.12493 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2024. Verfasst von Shengqi Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Traditional Chinese Medicine Syndrome, State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated H…. Hauptthemen laut MEDLINE: Paclitaxel, Extracellular Vesicles, Triple Negative Breast Neoplasms, Apoptosis. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund (Guangdong-Hong Kong-Macau Joint Lab), Guangzhou Science and Technology Project, Research Fund for Bajian Talents of Guangdong Provincial Hospital of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple‐negative breast cancer (TNBC) is the most aggressive breast cancer subtype and chemotherapy is the cornerstone treatment for TNBC. Regrettably, emerging findings suggest that chemotherapy facilitates pro‐metastatic changes in the tumour microenvironment. Extracellular vesicles (EVs) have been highly implicated in cancer drug resistance and metastasis. However, the effects of the EVs released from dying cancer cells on TNBC prognosis and corresponding therapeutic strategies have been poorly investigated. This study demonstrated that paclitaxel chemotherapy elicited CXCL1‐enriched EVs from apoptotic TNBC cells (EV‐Apo). EV‐Apo promoted the chemoresistance and invasion of co‐cultured TNBC cells by polarizing M2 macrophages through activating PD‐L1 signalling. However, baohuoside I (BHS) remarkably sensitized the co‐cultured TNBC cells to paclitaxel chemotherapy via modulating EV‐Apo signalling. Mechanistically, BHS remarkably decreased C‐X‐C motif chemokine ligand 1 (CXCL1) cargo within EV‐Apo and therefore attenuated macrophage M2 polarization by suppressing PD‐L1 activation. Additionally, BHS decreased EV‐Apo release by diminishing the biogenesis of intraluminal vesicles (ILVs) within multivesicular bodies (MVBs) of TNBC cells. Furthermore, BHS bound to the LEU104 residue of flotillin 2 (FLOT2) and interrupted its interaction with RAS oncogene family member 31 (RAB31), leading to the blockage of RAB31‐FLOT2 complex‐driven ILV biogenesis. Importantly, BHS remarkably chemosensitised paclitaxel to inhibit TNBC metastasis in vivo by suppressing EV‐Apo CXCL1 ‐induced PD‐L1 activation and M2 polarization of tumour‐associated macrophages (TAMs). This pioneering study sheds light on EV‐Apo CXCL1 as a novel therapeutic target to chemosensitise TNBC, and presents BHS as a promising chemotherapy adjuvant to improve TNBC chemosensitivity and prognosis by disturbing EV‐Apo CXCL1 biogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelExtracellular VesiclesTriple Negative Breast NeoplasmsApoptosisChemokine CXCL1HumansFemaleCell Line, TumorAnimalsMiceSignal TransductionTumor MicroenvironmentDrug Resistance, NeoplasmMacrophages

Stichwörter der Autor:innen

chemotherapydying cell signallingextracellular vesiclestriple‐negative breast cancertumour‐associated macrophage

Substanzen

PaclitaxelChemokine CXCL1CXCL1 protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Traditional Chinese Medicine Syndrome, State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • State Key Laboratory of Southwestern Chinese Medicine Resources, ChengduUniversity of Traditional Chinese Medicine, Chengdu, Sichuan, China.
  • Breast Disease Specialist Hospital of Guangdong Provincial Hospital ofChinese Medicine, Guangzhou, Guangdong, China.
  • The Research Center of Integrative Cancer Medicine, Disciplineof Integrated Chinese and Western Medicine, The Second Clinical College ofGuangzhou University of Chinese Medicine, Guangzhou, China.
  • Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou,…
  • Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, China.

ORCID-Profile: Zhiyu Wang

Förderung

  • 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund (Guangdong-Hong Kong-Macau Joint Lab)
  • Guangzhou Science and Technology Project
  • Research Fund for Bajian Talents of Guangdong Provincial Hospital of Chinese Medicine
  • Specific Research Fund for TCM Science and Technology of Guangdong Provincial Hospital of Chinese Medicine
  • National Natural Science Foundation of China
  • State Key Laboratory of Dampness Syndrome of Chinese Medicine
  • Science and Technology Planning Project of Guangdong Province
  • the Open Research Fund of Chengdu University of Traditional Chinese Medicine State Key Laboratory Southwestern Chinese Medicine Resources

Zitieren

APA

Wang, S., Li, J., Xu, S., Wang, N., Pan, B., Yang, B., Zheng, Y., Zhang, J., Peng, F., Peng, C., & Wang, Z. (2024). Baohuoside I chemosensitises breast cancer to paclitaxel by suppressing extracellular vesicle/CXCL1 signal released from apoptotic cells. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.12493

Vancouver

Wang S, Li J, Xu S, Wang N, Pan B, Yang B, et al. Baohuoside I chemosensitises breast cancer to paclitaxel by suppressing extracellular vesicle/CXCL1 signal released from apoptotic cells. Journal of Extracellular Vesicles. 2024. doi:10.1002/jev2.12493

BibTeX
@article{Wang2024,
  author = {Wang, Shengqi and Li, Jing and Xu, Shang and Wang, Neng and Pan, Bo and Yang, Bowen and Zheng, Yifeng and Zhang, Juping and Peng, Fu and Peng, Cheng and Wang, Zhiyu},
  title = {Baohuoside I chemosensitises breast cancer to paclitaxel by suppressing extracellular vesicle/CXCL1 signal released from apoptotic cells},
  journal = {Journal of Extracellular Vesicles},
  year = {2024},
  doi = {10.1002/jev2.12493}
}
Kostenlos starten →